Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β - PubMed (original) (raw)

doi: 10.1038/nn.2785. Epub 2011 Mar 27.

Affiliations

Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β

Jihoon Jo et al. Nat Neurosci. 2011 May.

Abstract

Amyloid-β(1-42) (Aβ) is thought to be a major mediator of the cognitive deficits in Alzheimer's disease. The ability of Aβ to inhibit hippocampal long-term potentiation provides a cellular correlate of this action, but the underlying molecular mechanism is only partially understood. We found that a signaling pathway involving caspase-3, Akt1 and glycogen synthase kinase-3β is an important mediator of this effect in rats and mice.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 2006 Jul 21;281(29):20315-25 - PubMed
    1. Biochem J. 2007 Dec 15;408(3):297-315 - PubMed
    1. Nature. 2003 May 22;423(6938):435-9 - PubMed
    1. Neuron. 2007 Mar 1;53(5):703-17 - PubMed
    1. J Neurosci Res. 2001 Jul 1;65(1):45-53 - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources